-
Notifications
You must be signed in to change notification settings - Fork 0
/
10.1016S1470-2045(17)30404-7.ann
81 lines (81 loc) · 2.6 KB
/
10.1016S1470-2045(17)30404-7.ann
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
T1 Biomarker 2235 2245 epirubicin
T4 Biomarker 279 291 capecitabine
T5 Disease 391 399 toxicity
T6 Protein 249 252 TTR
T7 Organism 2004 2017 4391 patients
T8 Disease 3354 3361 fatigue
T9 Organism 1596 1599 men
T11 Organism 3408 3416 patients
T12 Disease 3609 3627 hand-foot syndrome
T13 Biomarker 1032 1044 fluorouracil
T14 Disease 3523 3534 neutropenia
T15 Organism 3671 3684 1044 patients
T16 Biomarker 1209 1221 fluorouracil
T17 Condition 42 55 breast cancer
T18 Gene 678 686 excision
T19 Biomarker 1300 1315 m2 capecitabine
T20 Biomarker 1061 1077 cyclophosphamide
T21 Biomarker 881 883 mg
T22 Organism 2904 2907 men
T23 Biomarker 303 319 cyclophosphamide
T24 Organism 3403 3416 1045 patients
T25 Disease 89 97 toxicity
T27 Biomarker 1145 1147 mg
T28 Disease 3095 3103 toxicity
T29 Biomarker 1793 1803 epirubicin
T30 Organism 2026 2029 men
T31 Biomarker 3442 3452 epirubicin
T32 Biomarker 803 813 epirubicin
T33 Intervention 1581 1590 endocrine
T34 Biomarker 2823 2835 capecitabine
T35 Disease 3249 3260 neutropenia
T36 Gene 2304 2314 stratified
T37 Protein 2187 2190 TTR
T38 Gene 1452 1462 stratified
T39 Organism 354 362 patients
T40 Biomarker 1844 1856 capecitabine
T41 Biomarker 3784 3797 anthracycline
T42 Biomarker 1115 1117 mg
T43 Organism 2601 2609 patients
T44 Organism 3578 3586 patients
T45 Biomarker 3338 3348 epirubicin
T46 Biomarker 1292 1299 2500 mg
T48 Biomarker 2651 2663 capecitabine
T49 Organism 3676 3684 patients
T50 Biomarker 797 799 mg
T51 Biomarker 1151 1163 methotrexate
T52 Biomarker 934 944 epirubicin
T53 Condition 230 236 tumour
T55 Disease 3277 3284 fatigue
T56 Biomarker 1303 1315 capecitabine
T57 Organism 2037 2040 men
T58 Condition 1708 1721 breast cancer
T59 Protein 2482 2485 TTR
T60 Biomarker 1322 1324 mg
T61 Organism 505 513 patients
T62 Organism 3171 3179 patients
T63 Organism 3240 3243 1–4
T64 Disease 3551 3558 fatigue
T65 Biomarker 1014 1026 methotrexate
T66 Biomarker 274 291 oral capecitabine
T68 Biomarker 845 855 epirubicin
T69 Organism 2499 2507 patients
T70 Intervention 1118 1127 m2 orally
T71 Biomarker 3834 3846 capecitabine
T72 Biomarker 996 1012 cyclophosphamide
T73 Organism 2019 2029 4371 women
T74 Protein 1639 1642 TTR
T75 Biomarker 1203 1205 mg
T76 Condition 3644 3653 diarrhoea
T77 Organism 2785 2793 patients
T78 Biomarker 2392 2402 epirubicin
T79 Intervention 1484 1489 nodes
T80 Protein 884 897 pegfilgrastim
T82 Condition 607 653 high-risk node-negative operable breast cancer
T83 Biomarker 197 207 epirubicin
T84 Organism 3307 3315 patients
T85 Biomarker 2456 2466 epirubicin
T86 Organism 2168 2176 patients
T87 Protein 2620 2623 TTR
T88 Gene 2699 2709 stratified
R1 Relation Arg1:T53 Arg2:T6